On page 2354 of the 9 April 2015 issue, in Figure 3A, the dot plots for patient 2 at 3 and 6 months post–hematopoietic stem cell transplantation are incorrect. The dot plot labeled as the 3-month plot is a duplicate copy of the 1-month plot, and the one labeled as the 6-month plot is actually the 3-month plot.

Figure 3

Circulating γδ T cells in patients experiencing CMV reactivation. (A) Vδ1 and Vδ2 subsets (percentages are indicated) were identified in gated CD45+CD3+γδ+ cells by flow cytometry using PBMCs from 2 representative cases, evaluating both donors and patients 1, 3, and 6 months post-HSCT. Patient 7 did experience CMV reactivation, whereas patient 2 did not. (B) Comparative analysis of Vδ1 (left panel) and Vδ2 (right panel) T cells was performed in patients who did experience CMV reactivation (white plots) and in those who did not (gray plots). Vδ1 and Vδ2 cells were identified in gated CD45+CD3+γδ+ cells. (C) Intranuclear expression of Ki-67 (filled profiles) shows proliferating status in CD45+CD3+γδ+, CD45+CD3+γδ+Vδ1+, and CD45+CD3+γδ+Vδ2+ cells. Empty profiles represent staining with isotype control. (D) Percentage of naïve, CM, EM, and TD was evaluated by flow cytometry in gated CD45+CD3+γδ+Vδ1+ T cells collected from patients who did experience CMV reactivation (white plots) and in those who did not (gray plots) 3 months after HSCT. Pooled results are shown. Whisker lines represent the highest and lowest values; horizontal lines represent median values.

Figure 3

Circulating γδ T cells in patients experiencing CMV reactivation. (A) Vδ1 and Vδ2 subsets (percentages are indicated) were identified in gated CD45+CD3+γδ+ cells by flow cytometry using PBMCs from 2 representative cases, evaluating both donors and patients 1, 3, and 6 months post-HSCT. Patient 7 did experience CMV reactivation, whereas patient 2 did not. (B) Comparative analysis of Vδ1 (left panel) and Vδ2 (right panel) T cells was performed in patients who did experience CMV reactivation (white plots) and in those who did not (gray plots). Vδ1 and Vδ2 cells were identified in gated CD45+CD3+γδ+ cells. (C) Intranuclear expression of Ki-67 (filled profiles) shows proliferating status in CD45+CD3+γδ+, CD45+CD3+γδ+Vδ1+, and CD45+CD3+γδ+Vδ2+ cells. Empty profiles represent staining with isotype control. (D) Percentage of naïve, CM, EM, and TD was evaluated by flow cytometry in gated CD45+CD3+γδ+Vδ1+ T cells collected from patients who did experience CMV reactivation (white plots) and in those who did not (gray plots) 3 months after HSCT. Pooled results are shown. Whisker lines represent the highest and lowest values; horizontal lines represent median values.

Close modal

The corrected Figure 3 is shown below. The authors apologize for this mistake. The correction does not alter the results or conclusions of the study. The error has been corrected in the online version, which now differs from the print version.